Post Midterm Diseases Flashcards
PKU
Symptom: Moussey urine Accumulation of: Phenylalanine and phenylpyruvic acid Enzyme deficiency: PAH if classic BH2 Reductase if malignant Dietary restriction and TTO: PHE
Alkaptonuria
Symptom: Black Urine
Accumulation of: Homogentistic acid
Enzyme deficiency: Hongentistis acid oxidase
Dietary restriction/TTO: Benign so no TTO
Tyrosinemia type 1
Symptom: Cabbage like urine
Accumulation of: Fumaryl acetoacetic acid
Enzyme deficiency: Fumaryl acetoacetic acid Hydroxylase
Dietary restriction/TTO: PHE and TYR
Maple Syrup Urine Disease (MSUD)
Symptom: Maple syrup urine Accumulation of: B C Acids Enzyme deficiency: BCKD Dietary restriction/TTO: Restrict I,L,V, give TPP (Vitamin B1)
Methylmalonic Aciduria
Symptom: Methylmalonic acid in urine
Accumulation of: Methylmalonic acid
Enzyme deficiency: B12 Cofactor of Methylmalonic acid mutase
Lesch-Nyhan Syndrome
X-linked. Deficiency of the enzyme hypoxythine-guanine phosphoribosyltransferase (HGPRT). Results in an inability or salvage purines hypoxanthine and guanine. End product of degradation is uric acid (excess found in urine) (baby diaper: orange crystals)
Causes: severe mental retardation, self-mutilation, involuntary movements, and gout.
Causes increased PRPP levels and an increased in de novo purine synthesis.
Severe Combined Immunodeficiency Syndrome (SCIDS)
cause: Adenosine deaminase (ADA) deficiency.
DNA is not synthesized in T-cells and B-cells b/c of an accumulation of dATP. (Lymphocytopenia: T-cell and B-cell depletion.) (dATP is an inhibitor of ribonucleotide reductase, and therefore, of DNA synthesis.
PNP Deficiency
Purine nucleoside phosphorylase (PNP) deficiency causes impairment of T-cell fxn.
Characterized by decreased uric acid production and increased purine nucleosides and nucleotides.
Gout
Characterized by hyperuricemia; acute arthritic joint inflammation caused by deposition of uric acid crystals.
Can be diagnosed by presence of negatively birefringent monosodium urate crystals in aspirated synovial fluid examined by polarized-light microscopy
Affects men and women of any age
Primary Gout
Genetic and mainly affects males over 30 years old.
Secondary Gout
Brought on by a number of disorders including leukemia, polycythemia, HGPRT deficiency, cancer treatment with antimetabolites, or chronic renal insufficiency.
Acute Intermittent Porphyria
Deficient enzyme: HMB synthase (porphobilinogen deaminase)
Autosomal dominant disorder.
Result: ALA activity is high as ALA synthase is not feed-back inhibited by heme/hemin and instead enzyme synthesis is activated @ low heme/hemin (derepression).
Characterized by: ALA and Porphobilinogen in blood and urine.
–AIP occurs in pts who are treated with specific drugs that inhibit cytochrome p450 synthesis. Can also be triggered by infections, ethanol abuse or abnormal estrogen metabolism.
-DOES NOT LEAD TO PHOTOSENSITIVITY
Acute Intermittent Porphyria Signs and Symtoms
- very severe abdominal pain
- highly agitated state, tachycardia, respiratory problems, nausea
- confusion, mental disturbances
- lower extremity weakness
- pts NOT photosensitive, however ALA and porphobilinogen accumulate at high levels and can act as neurotransmitters.
Acute Intermittent Porphyria detection
Porphobilinogen in urine can be detected by rapid dipstick method. Later on, ALA and porphobilinogen conc can be measured in lab.
- Normal urine color changes to dark purple after 24 exposure to light and air.
- Colorless porphobilinogen changed to dark colored porphobilin.
Acute intermittent Porphyria treatment
Treatment: pain medication, intavenous glucose and saline infusion and it can include intravenous hemin admin in severe cases.
DO NOT admin barbituates to calm pt. down, as stimulation of CYP450 synthesis can worsen situation and even lead to death.